Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels

被引：0

作者：

Sonneveld, Milan ^{[1
]}

Chiu, S. M. ^{[2
]}

Park, Jun Yong ^{[3
]}

Kaewdech, Apichat ^{[4
]}

Seto, Wai-Kay ^{[5
]}

Tanaka, Yasuhito ^{[6
]}

Carey, Ivana ^{[7
]}

Papatheodoridi, Margarita ^{[8
]}

van Bommel, Florian ^{[9
]}

Brakenhoff, Sylvia ^{[1
]}

Berg, Thomas ^{[9
]}

Zoulim, Fabien ^{[10
]}

Ahn, Sang Hoon ^{[3
]}

Dalekos, George ^{[11
]}

Erler, Nicole ^{[1
]}

Zu Siederdissen, Christoph Hoener ^{[12
]}

Wedemeyer, Heiner ^{[12
]}

Cornberg, Markus ^{[12
]}

Yuen, Man-Fung ^{[5
]}

Agarwal, Kosh ^{[7
]}

Boonstra, Andre ^{[1
]}

Buti, Maria ^{[13
]}

Piratvisuth, T. ^{[4
]}

Papatheodoridis, George ^{[8
]}

Chen, Chien-Hung ^{[2
]}

Maasoumy, Benjamin ^{[12
]}

机构：

[1] Erasmus MC, Rotterdam, Netherlands

[2] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[3] Yonsei Univ, Coll Med, Seoul, South Korea

[4] Prince Songkla Univ, Tambon Kho Hong, Thailand

[5] Univ Hong Kong, Hong Kong, Peoples R China

[6] Kumamoto Univ, Kumamoto, Japan

[7] Kings Coll Hosp London, London, England

[8] Laiko Hosp, Athina, Greece

[9] Univ Hosp Leipzig, Leipzig, Germany

[10] Inserm, Lyon, France

[11] Gen Univ Hosp Larissa, Larisa, Greece

[12] Med Hsch, Hannover, Germany

[13] Hosp Univ Vall dHebron, Barcelona, Spain

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT344

引用

页码：S824 / S825

页数：2

共 50 条

[41] Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels [J].

Hall, Samuel A. L. ;

Burns, Gareth S. ;

Anagnostou, Despina ;

Vogrin, Sara ;

Sundararajan, Vijaya ;

Ratnam, Dilip ;

Levy, Miriam T. ;

Lubel, John S. ;

Nicoll, Amanda J. ;

Strasser, Simone, I ;

Sievert, William ;

Desmond, Paul, V ;

Ngu, Meng C. ;

Angus, Peter ;

Sinclair, Marie ;

Meredith, Christopher ;

Matthews, Gail ;

Revill, Peter A. ;

Jackson, Kathy ;

Littlejohn, Margaret ;

Bowden, D. Scott ;

Locarnini, Stephen A. ;

Visvanathan, Kumar ;

Thompson, Alexander J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) :310-320

[42] Survival outcomes of patients with hepatocellular carcinoma and HBsAg seroconversion after nucleoside analogue therapy: a case-matched study [J].

Yip, Vincent ;

Cheung, Tan T. ;

Chan, Albert C. ;

Chok, K. C. H. ;

Dai, W. C. ;

Tsang, S. H. ;

Lo, C. M. ;

Poon, R. T. ;

Yau, T. .

BRITISH JOURNAL OF SURGERY, 2014, 101 :7-8

[43] Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data metaanalysis (create study) [J].

Sonneveld, Milan ;

Park, Jun Yong ;

Seto, Wai-Kay ;

Tanaka, Yasuhito ;

Carey, Ivana ;

Papatheodoridi, Margarita ;

Zoulim, Fabien ;

Ahn, Sang Hoon ;

Dalekos, George ;

Siederdissen, Christoph Hoener Zu ;

Cornberg, Markus ;

Yuen, Man-Fung ;

Agarwal, Kosh ;

Boonstra, Andre ;

Buti, Maria ;

Papatheodoridis, George ;

Maasoumy, Benjamin .

JOURNAL OF HEPATOLOGY, 2020, 73 :S873-S874

[44] FINAL RESULTS OF THE HBV-STOP STUDY - LOW BASELINE HBsAg LEVELS PREDICT DISEASE REMISSION AND HBsAg LOSS AFTER STOPPING NUCLEOT(S)IDE ANALOGUES IN CHRONIC HEPATITIS B E-ANTIGEN NEGATIVE PATIENTS [J].

Hall, Samuel ;

Burns, Gareth ;

Anagnostou, Despina ;

Vogrin, Sara ;

Sundararajan, Vijaya ;

Ratnam, Dilip T. ;

Levy, Miriam T. ;

Lubel, John S. ;

Nicoll, Amanda J. ;

Strasser, Simone I. ;

Sievert, William ;

Desmond, Paul V. ;

Ngu, Meng Chong ;

Angus, Peter W. ;

Maree, Sinclair ;

Meredith, Christopher ;

Matthews, Gail ;

Revill, Peter ;

Jackson, Kathy ;

Bonanzinga, Sara ;

Canchola, Jesse ;

Kuchta, Alison ;

Torres, Jason ;

Bowden, Scott ;

Locarnini, Stephen ;

Visvanathan, Kumar ;

Thompson, Alexander .

HEPATOLOGY, 2021, 74 :482A-483A

[45] Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue [J].

Wu, Li-Li ;

Li, Xiao-Yan ;

Deng, Kai ;

Lin, Bing-Liang ;

Deng, Hong ;

Xie, Dong-Ying ;

Zhang, Geng-Lin ;

Zhao, Qi-Yi ;

Mo, Zhi-Shuo ;

Huang, Yue-Hua ;

Gao, Zhi-Liang .

LIVER RESEARCH, 2023, 7 (02) :136-144

[46] Low baseline HBsAg levels predict disease remission and HBsAg loss after stopping nucleot(s)ide analogs in chronic hepatitis B e-antigen-negative patients: Final results of the HBV-STOP study [J].

Hall, S. ;

Burns, G. ;

Anagnostou, D. ;

Vogrin, S. ;

Sundararajan, V. ;

Ratnam, D. ;

Levy, M. ;

Lubel, J. ;

Nicoll, A. ;

Strasser, S. ;

Sievert, W. ;

Desmond, P. ;

Ngu, M. ;

Angus, P. ;

Sinclair, M. ;

Meredith, C. ;

Matthews, G. ;

Revill, P. ;

Jackson, K. ;

Bowden, S. ;

Locarnini, S. ;

Visvanathan, K. ;

Thompson, A. .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 :65-65

[47] HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy [J].

Sonneveld, Milan J. ;

Chiu, Shao-Ming ;

Park, Jun Yong ;

Brakenhoff, Sylvia M. ;

Kaewdech, Apichat ;

Seto, Wai-Kay ;

Tanaka, Yasuhito ;

Carey, Ivana ;

Papatheodoridi, Margarita ;

Colombatto, Piero ;

van Bommel, Florian ;

Janssen, Harry L. ;

Berg, Thomas ;

Zoulim, Fabien ;

Ahn, Sang Hoon ;

Dalekos, George N. ;

Erler, Nicole S. ;

Brunetto, Maurizia ;

Wedemeyer, Heiner ;

Cornberg, Markus ;

Yuen, Man-Fung ;

Agarwal, Kosh ;

Boonstra, Andre ;

Buti, Maria ;

Piratvisuth, Teerha ;

Papatheodoridis, George ;

Chen, Chien-Hung ;

Maasoumy, Benjamin .

GASTROENTEROLOGY, 2024, 166 (01) :168-177.e8

[48] TREATMENT WITHDRAWAL AFTER LONG-TERM NUCLEOTIDE ANALOGUE THERAPY WITH OR WITHOUT PEGINTERFERON: PREDICTORS OF ALT FLARES, HBsAg DECLINE AND ACTIVE DISEASE [J].

Feld, Jordan J. ;

Wahed, Abdus ;

Ghany, Marc G. ;

Khalili, Mandana ;

Terrault, Norah ;

Perrillo, Robert P. ;

Di Bisceglie, Adrian M. ;

Fried, Michael W. ;

Belle, Steve ;

Janssen, Harry L. A. ;

Lok, Anna S. .

HEPATOLOGY, 2021, 74 :501A-502A

[49] HBV DNA relapse after stopping nucleoside analogue therapy in patients with HBsAg loss: Detectable pre-genomic HBV RNA is a better predictor of relapse than ultra-sensitive HBsAg-'implications for HBV cure' [J].

Carey, Ivana ;

Gersch, Jeffrey ;

Moigboi, Christiana ;

Bruce, Matthew ;

Kuhns, Mary ;

Cloherty, Gavin ;

Dusheiko, Geoffrey ;

Agarwal, Kosh .

JOURNAL OF HEPATOLOGY, 2019, 70 (01) :E254-E254

[50] TREATMENT DISCONTINUATION AFTER HBSAG LOSS IS SAFE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS/TIDE ANALOGS: A RETROSPECTIVE MULTICENTER STUDY (HEBESAS) [J].

Suarez, E. ;

Simon, M. A. ;

Buti, M. ;

Prieto, M. ;

Pascasio, J. M. ;

Rodriguez, M. ;

Casanovas, T. ;

Crespo, J. ;

Arenas, J. ;

Gomez, R. ;

Figueruela, B. ;

Diago, M. ;

Morillas, R. Ma. ;

Zozaya, J. M. ;

Calleja, J. L. ;

Casado, M. ;

Molina, E. ;

Fuentes, J. .

JOURNAL OF HEPATOLOGY, 2016, 64 :S588-S588

← 1 2 3 4 5 →